Le Lézard
Classified in: Health
Subjects: PDT, TDS, FDA, FVT

Gramercy Extremity Orthopedics Receives FDA 510(k) Clearance for GEOtm Bone Screw System


DALLAS, Jan. 26, 2017 /PRNewswire/ -- Gramercy Extremity Orthopedics (GEO) today announced it received the U.S. Food and Drug Administration's (FDA) 510(k) clearance for the GEOtm Bone Screw System, which can be used for bone fractures, osteotomies, arthrodesis, osteochondritis, and tendon reattachments. As the first offering in the company's product line, this marks a major milestone for Gramercy Extremity Orthopedics.

The GEOtm Bone Screw System offers a comprehensive array of low profile titanium screw lengths, diameters, thread lengths and fully threaded options. All GEOtm Bone Screws are double sterile packaged, self-drilling, self-tapping, reverse-cutting with variable length short and long threads and a hexalobe head to provide additional stability and torque transfer with less potential for head stripping. All instruments within the GEOtm Bone Screw system are also double sterile packaged in single use kits to ensure a new and sterilized instrument is used every surgery.

"We are very pleased with the clearance of the GEOtm Bone Screw System," says Michael P. Simpson, President and CEO of Gramercy Extremity Orthopedics. "GEO is in the business of providing solutions to complex problems for our customer, and this clearance is one more step in that offering."

GEO will be exhibiting at the ACFAS Scientific Conference, Las Vegas, Feb 27th ? Mar 1st, 2017. Booth #1413.

About Gramercy Extremity Orthopedics: 

GEO was formed from the idea that there could exist a more cost effective, user-friendly way to supply Orthopedic Medical Implants in today's healthcare environment. This is accomplished through the use of technology, a groundbreaking Point-of-Sale delivery system and GEO designed best in class sterilized single use orthopedic implants and instruments. GEO is the only solution that provides a significant opportunity to lower real operating costs by creating efficiencies and controls throughout the delivery and consumption of orthopedic implants.

GRAMERCY EXTREMITY ORTHOPEDICStm and GEOtm are proprietary trademarks of Gramercy Extremity Orthopedics, LLC. All rights reserved.

(www.gramercyortho.com)

Press Media Contact:

Michael Nugent
855-436-2278 ext 103
[email protected]

 

SOURCE Gramercy Extremity Orthopedics


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...



News published on and distributed by: